TrialNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2018

JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.

Katherine R Tuttle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.